Trexquant Investment LP Enanta Pharmaceuticals Inc Transaction History

Trexquant Investment LP

  • $8.01 Billion
  • Q1 2025

A detailed history of Trexquant Investment LP transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Trexquant Investment LP holds 290,059 shares of ENTA stock, worth $2.09 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
290,059
Previous 135,954 113.35%
Holding current value
$2.09 Million
Previous $781,000 104.99%
% of portfolio
0.02%
Previous 0.01%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025
BUY
$4.82 - $8.49 $742,786 - $1.31 Million
154,105 Added 113.35%
290,059 $1.6 Million
Q4 2024

Feb 12, 2025
BUY
$5.75 - $12.99 $385,480 - $870,849
67,040 Added 97.28%
135,954 $781,000
Q3 2024

Nov 12, 2024
SELL
$10.05 - $16.54 $100,590 - $165,548
-10,009 Reduced 12.68%
68,914 $714,000
Q2 2024

Aug 13, 2024
SELL
$11.43 - $17.02 $191,063 - $284,506
-16,716 Reduced 17.48%
78,923 $1.02 Million
Q1 2024

May 14, 2024
SELL
$10.08 - $17.46 $231,567 - $401,108
-22,973 Reduced 19.37%
95,639 $1.67 Million
Q4 2023

Feb 09, 2024
SELL
$8.18 - $10.78 $114,102 - $150,370
-13,949 Reduced 10.52%
118,612 $1.12 Million
Q3 2023

Nov 13, 2023
BUY
$11.09 - $22.13 $1.47 Million - $2.93 Million
132,561 New
132,561 $1.48 Million
Q3 2022

Nov 14, 2022
SELL
$48.29 - $71.27 $66,157 - $97,639
-1,370 Reduced 21.91%
4,882 $253,000
Q2 2022

Aug 11, 2022
BUY
$38.13 - $76.93 $238,388 - $480,966
6,252 New
6,252 $296,000
Q3 2021

Nov 12, 2021
SELL
$41.02 - $58.65 $326,437 - $466,736
-7,958 Closed
0 $0
Q2 2021

Aug 12, 2021
BUY
$43.76 - $53.11 $348,242 - $422,649
7,958 New
7,958 $350,000
Q1 2021

May 13, 2021
SELL
$41.69 - $54.95 $296,999 - $391,463
-7,124 Closed
0 $0
Q4 2020

Feb 11, 2021
SELL
$41.16 - $47.47 $350,436 - $404,159
-8,514 Reduced 54.44%
7,124 $300,000
Q3 2020

Nov 06, 2020
BUY
$43.36 - $53.53 $338,294 - $417,641
7,802 Added 99.57%
15,638 $716,000
Q2 2020

Aug 07, 2020
BUY
$46.37 - $57.58 $363,355 - $451,196
7,836 New
7,836 $393,000
Q3 2019

Nov 08, 2019
SELL
$60.08 - $88.17 $229,745 - $337,162
-3,824 Closed
0 $0
Q2 2019

Aug 09, 2019
SELL
$81.3 - $97.35 $908,934 - $1.09 Million
-11,180 Reduced 74.51%
3,824 $323,000
Q1 2019

May 13, 2019
BUY
$69.08 - $105.66 $1.04 Million - $1.59 Million
15,004 New
15,004 $1.43 Million
Q3 2018

Nov 09, 2018
SELL
$85.46 - $126.37 $450,032 - $665,464
-5,266 Closed
0 $0
Q2 2018

Aug 07, 2018
BUY
$81.85 - $120.51 $431,022 - $634,605
5,266 New
5,266 $610,000
Q1 2018

May 03, 2018
SELL
$57.91 - $92.15 $499,184 - $794,333
-8,620 Closed
0 $0
Q4 2017

Feb 09, 2018
BUY
$45.65 - $59.37 $393,503 - $511,769
8,620
8,620 $506,000

Others Institutions Holding ENTA

# of Institutions
112
Shares Held
18.8M
Call Options Held
5.6K
Put Options Held
13.9K
View Full List

About ENANTA PHARMACEUTICALS INC

ENTA Quotes by TradingView
  • Ticker ENTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,724,900
  • Market Cap $149M
  • Description
  • Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...
More about ENTA
Track This Portfolio

Track Trexquant Investment LP Portfolio

Follow Trexquant Investment LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email